MedTrace Logo

Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.

NCT03570879 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-09-30

No results posted yet for this study

Summary

Laparoscopic myomectomy represents the fertility-sparing gold standard approach for the management of subserosal and intramural uterine myomas: this technique allows faster recovery, less complications and improved surgical outcomes than laparotomy.

Despite these validated cornerstones of minimally invasive gynecology, the best approach for specimen retrieval is still debated. Among these approaches, surgical specimen retrieval after laparoscopic myomectomy could be performed by mini-laparotomy, by power morcellation using morcellator inserted through one of the ancillary trocars, or by transvaginal extraction through an endobag inserted at level of the posterior vaginal fornix (between the utero-sacral ligaments).

Unfortunately, mini-laparotomy has poor esthetic outcome and does not conform the current standards of minimally invasive surgery.

In addition, on 24 November 24 2014 the Food and Drug Administration updated a Safety Communication about Power Morcellation, warning against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for treatment of fibroids, due to the risk of spreading an unsuspected uterine sarcoma within the abdomen and pelvis.

Considering this scenario, transvaginal extraction may represents a feasible approach for specimen retrieval. In this view, the current study aims to retrospectively compare surgical outcomes in women that underwent laparoscopic myomectomy with subsequent power morcellation (before the issuing of the abovementioned Safety Communication by the Food and Drug Administration) or transvaginal extraction (after the issuing of the abovementioned Safety Communication by the Food and Drug Administration) of the surgical specimens.

Conditions

  • Myoma;Uterus

Interventions

DEVICE

Power morcellation

Power morcellation of surgical specimens after laparoscopic myomectomy.

PROCEDURE

Transvaginal extraction

Transvaginal extraction of surgical specimens after laparoscopic myomectomy.

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    lead OTHER

Principal Investigators

  • Antonio Simone Laganà, M.D. · Università degli Studi dell'Insubria

  • Jvan Casarin, M.D. · Università degli Studi dell'Insubria

  • Antonella Cromi, M.D., Ph.D. · Università degli Studi dell'Insubria

  • Fabio Ghezzi, M.D. · Università degli Studi dell'Insubria

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-05-01
Completion
2024-05-01
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03570879 on ClinicalTrials.gov